Potential new treatment for prostate cancer developedFebruary 7th, 2009 - 2:28 pm ICT by ANI
Washington, Feb 7 (ANI): Scientists at Melbourne’’s Burnet Institute claim to have developed a potential new treatment for prostate cancer patients.
The team led by Associate Professor Pei Xiang Xing, head of the Burnet Institute’’s Cancer Immunotherapy, has produced a monoclonal antibody to a unique tumour marker for the treatment of prostate cancer.
The monoclonal antibody is directed at cancer-producing cells carrying the specific molecule known as PIM-1, which is responsible for cell survival, proliferation and differentiation.
Over-expression of PIM-1 plays a critical role in the development, progression and metastasis of prostate cancer and other cancers such as leukaemia.
The researchers found that the monoclonal antibody significantly inhibited cancer cell growth when used in laboratory models of prostate cancer.
During the study, the team demonstrated that the monoclonal antibody binds to PIM-1 present in cancer cells and creates a chain of events leading to the death of the cells.
Moreover, the therapeutic effect was improved by combination of the antibody with other drugs currently used to treat prostate cancer.
“This is an exciting step in the development of new treatments for patients with prostate cancer with very promising laboratory-test results,” said Professor Crabb. (ANI)
- Potential new treatment for prostate cancer developed - Feb 09, 2009
- Life work culminates in testing of cancer therapy in humans - Mar 24, 2011
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- Targeted treatment for prostate cancer to be tested - Apr 17, 2010
- Search for cancer 'biomarkers' to make treatments more effective - Jan 11, 2011
- Scientists 1 step closer to developing treatment for chikungunya - Feb 16, 2011
- Pomegranate juice could be key to new cancer therapies - Dec 13, 2010
- Now, a disposable device to identify aggressive breast cancers - Sep 29, 2010
- Genetic pathways involved in breast cancer identified - Mar 04, 2011
- How HRT and the Pill can lead to breast cancer - Sep 30, 2010
- Now, a tiny white bread mint like capsule to track cancer in the body - Mar 16, 2011
- India-Cuba joint discovery in biomedical sciences wins award - Jul 19, 2011
- Protein that spurs spread of prostate cancer discovered - May 20, 2010
- Common white flower may harbour leukaemia cure - Apr 30, 2010
- Turning diseased blood cells to stem cells may reveal cancer quickly - Feb 05, 2011
Tags: burnet institute, cancer cell growth, cancer cells, cancer immunotherapy, cancers, cell survival, critical role, differentiation, laboratory models, laboratory test results, metastasis, molecule, monoclonal antibody, pei, pim, prostate cancer, prostate cancer patients, therapeutic effect, treatment of prostate cancer, tumour marker